CH356457A - Process for the preparation of new phenothiazines - Google Patents
Process for the preparation of new phenothiazinesInfo
- Publication number
- CH356457A CH356457A CH356457DA CH356457A CH 356457 A CH356457 A CH 356457A CH 356457D A CH356457D A CH 356457DA CH 356457 A CH356457 A CH 356457A
- Authority
- CH
- Switzerland
- Prior art keywords
- carbon atoms
- hydrogen atom
- phenothiazines
- alkyl radical
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 150000002990 phenothiazines Chemical class 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- -1 saturated aliphatic aldehyde Chemical class 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 229950000688 phenothiazine Drugs 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-L ethane-1,2-disulfonate Chemical compound [O-]S(=O)(=O)CCS([O-])(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-L 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229940005494 general anesthetics Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- ADDQUOLYROTOKS-UHFFFAOYSA-N iodomethanol Chemical compound OCI ADDQUOLYROTOKS-UHFFFAOYSA-N 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Procédé de préparation de nouvelles phénothiazines La présente invention a pour objet un procédé de préparation de nouvelles phénothiazines, de for- mules
EMI0001.0010
EMI0001.0011
dans lesquelles Y représente un atome d'hydrogène ou un radical alcoyle de 1 à 5 atomes de carbone, Y' représente un radical alcoyle de 1 à 5 atomes de carbone,
B représente un radical hydrocarboné ali phatique, à chaîne droite ou ramifiée, de 2 à 5 ato mes de carbone, tel que, par exemple, éthylène, pro pylène, isobutylène, triméthylène, tétraméthylène, et B' représente un radical hydrocarboné aliphatique, à chaîne droite ou ramifiée, de 2 à 6 atomes de car bone.
Le procédé selon l'invention est caractérisé en ce que l'on alcoyle le groupe ammo d'un composé de formule
EMI0001.0030
dans laquelle Yl représente un atome d'hydrogène ou un radical alcoyle de 1 à 5 atomes de carbone,
ou au moins l'un des groupes amino d'un composé de formule
EMI0001.0034
dans laquelle les restes. Y1 et Yi' représentent chacun un atome d'hydrogène ou un radical alcoyle de 1 à 5 atomes de carbone, l'un au moins desdits restes étant un atome d'hydrogène,
en faisant réagir ledit composé avec un aldéhyde aliphatique saturé de 1 à 5 atomes de carbone et un agent de réduction.
Certaines des phénothiazines obtenues par le procédé selon l'invention possèdent dans le reste B ou B' un atome de carbone asymétrique et peuvent donc exister sous forme racémique ou optiquement active.
Les phénothiazines optiquement actives peu vent être obtenues, en partant de matières premières elles-mêmes optiquement actives ou à partir des racémiques correspondants par résolution optique. Les produits obtenus, par le procédé selon l'in vention sont tous caractérisés par une activité mar quée sur le système nerveux central ;
cette activité en permet l'emploi d'une façon générale comme anti émétiques, potentialisateurs d'anesthésiques géné raux, neuroleptiques. En outre, certains d'entre eux, en particulier ceux substitués en position 10 du noyau de la phénothiazine par les radicaux
EMI0002.0009
présentent une activité antihistaminique très impor tante.
Enfin, les phénothiazines comportant deux restes
EMI0002.0012
sont particulièrement intéressantes comme spasmoly- tiques et anesthésiques locaux.
Pour l'usage pharmaceutique, les produits obtenus par le procédé selon l'invention peuvent être utilisés sous forme de sels thérapeutiquement acceptables, tels que :
chlorhydrate, phosphate, nitrate, sulfate, maléate, fumarate, citrate, tartrate, oxalate, méthane- sulfonate, éthanedisulfonate, ou de composés ammo nium quaternaire thérapeutiquement acceptables, tels que:
chloro-, bromo- ou iodométhylate ou -éthylate, chloro- ou bromobenzylate ou -allylate.
<I>Exemple</I> 2,8g de méthylthio-3-(amino-3'-propyl)-10- phénothiazine en solution dans 30 cm3 de dioxane pur sont neutralisés avec 9,2 cm3 d'acide chlor hydrique normal.
On ajoute à cette solution 22,1 cm-3 d'une solution aqueuse de formol à 30 % et 0,2 g d'oxyde de platine, puis agite fortement le mélange sous légère pression d'hydrogène à température ordi naire pendant 48 heures. Après élimination du pla tine par filtration et évaporation du solvant sous pression réduite, le résidu obtenu est traité par 50 cm3 d'acide chlorhydrique normal. L'insoluble est filtré et la solution acide alcalinisée avec de la les sive de soude (d= 1,33).
Après extraction à l'éther, séchage de la solution éthérée sur sulfate de sodium et distillation du solvant, on obtient 0,2 g de méthyl- thio -3 - (diméthylamino - 3'-propyl)-10-phénothiazine, dont le picrate fond à 135o.
La méthylthio-3-(amino-3'-propyl)-10-phénothi- azine de départ - dont l'oxalate acide fond à 198 est préparée par chauffage dans le toluène à 1100 de la méthylthio-3-(tosyloxy-3'-propyl)-10-phénothiazine avec de l'ammoniac en excès.
Les points de fusion indiqués ci-dessus ont été déterminés au banc Kofler.
Process for the preparation of new phenothiazines The present invention relates to a process for the preparation of new phenothiazines, of formulas
EMI0001.0010
EMI0001.0011
in which Y represents a hydrogen atom or an alkyl radical of 1 to 5 carbon atoms, Y 'represents an alkyl radical of 1 to 5 carbon atoms,
B represents an aliphatic hydrocarbon radical, straight or branched chain, of 2 to 5 carbon atoms, such as, for example, ethylene, propylene, isobutylene, trimethylene, tetramethylene, and B 'represents an aliphatic hydrocarbon radical, with straight or branched chain, from 2 to 6 carbon atoms.
The process according to the invention is characterized in that the ammo group of a compound of formula is alkylated
EMI0001.0030
in which Yl represents a hydrogen atom or an alkyl radical of 1 to 5 carbon atoms,
or at least one of the amino groups of a compound of formula
EMI0001.0034
in which the remains. Y1 and Yi 'each represent a hydrogen atom or an alkyl radical of 1 to 5 carbon atoms, at least one of said residues being a hydrogen atom,
by reacting said compound with a saturated aliphatic aldehyde of 1 to 5 carbon atoms and a reducing agent.
Some of the phenothiazines obtained by the process according to the invention have in the remainder B or B 'an asymmetric carbon atom and can therefore exist in racemic or optically active form.
Optically active phenothiazines can be obtained starting from the starting materials which are themselves optically active or from the corresponding racemates by optical resolution. The products obtained by the process according to the invention are all characterized by an activity marked on the central nervous system;
this activity allows its use in general as anti-emetics, potentiators of general anesthetics, neuroleptics. In addition, some of them, in particular those substituted in position 10 of the phenothiazine ring by the radicals
EMI0002.0009
exhibit very strong antihistamine activity.
Finally, phenothiazines with two residues
EMI0002.0012
are particularly useful as spasmolytics and local anesthetics.
For pharmaceutical use, the products obtained by the process according to the invention can be used in the form of therapeutically acceptable salts, such as:
hydrochloride, phosphate, nitrate, sulfate, maleate, fumarate, citrate, tartrate, oxalate, methanesulfonate, ethanedisulfonate, or therapeutically acceptable quaternary ammonium compounds, such as:
chloro-, bromo- or iodomethoxide or -ethoxide, chloro- or bromobenzylate or -allylate.
<I> Example </I> 2.8 g of methylthio-3- (amino-3'-propyl) -10-phenothiazine dissolved in 30 cm3 of pure dioxane are neutralized with 9.2 cm3 of normal hydrochloric acid.
22.1 cm-3 of an aqueous solution of 30% formalin and 0.2 g of platinum oxide are added to this solution, then the mixture is vigorously stirred under slight hydrogen pressure at ordinary temperature for 48 hours. . After removal of the platinum by filtration and evaporation of the solvent under reduced pressure, the residue obtained is treated with 50 cm3 of normal hydrochloric acid. The insoluble matter is filtered off and the acidic solution made alkaline with sodium hydroxide (d = 1.33).
After extraction with ether, drying of the ethereal solution over sodium sulfate and distillation of the solvent, 0.2 g of methyl-thio -3 - (dimethylamino - 3'-propyl) -10-phenothiazine is obtained, including the picrate melts at 135o.
The starting methylthio-3- (amino-3'-propyl) -10-phenothiazine - the acid oxalate of which melts at 198 is prepared by heating in toluene at 1100 of methylthio-3- (tosyloxy-3 ' -propyl) -10-phenothiazine with excess ammonia.
The melting points indicated above were determined on the Kofler bench.
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR356457X | 1955-11-25 | ||
| FR160856X | 1956-08-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH356457A true CH356457A (en) | 1961-08-31 |
Family
ID=26213844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH356457D CH356457A (en) | 1955-11-25 | 1956-11-14 | Process for the preparation of new phenothiazines |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH356457A (en) |
-
1956
- 1956-11-14 CH CH356457D patent/CH356457A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870001151A (en) | Method for preparing novel phenylethanol aminotetraline having lipolytic activity | |
| FR2674849A1 (en) | NOVEL N-CYCLOHEXYL BENZAMIDE OR THIOBENZAMIDE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS | |
| US2784233A (en) | Tertiary n- | |
| FR2625678A1 (en) | Anorexigenic agents based on N-(3-quinuclidinyl)benzamides or -thiobenzamides | |
| MC1357A1 (en) | 2,3-INDOLEDIONE DERIVATIVES | |
| CH356457A (en) | Process for the preparation of new phenothiazines | |
| FR2658195A1 (en) | NEW DERIVATIVES OF 20, 21-DINOREBURNAMENINE, PROCESS FOR THE PREPARATION THEREOF AND THE NEW INTERMEDIATES THUS OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS COMPRISING THE SAME. | |
| EP0005091B1 (en) | Monosubstituted piperazines, processes for their preparation and pharmaceutical compositions containing them | |
| US3096244A (en) | Substituted butyric acid amide and analgesia | |
| US2791603A (en) | Process for preparing carbamates of tertiary acetylenic carbinols | |
| US3320277A (en) | 3-amino-3-hydroxymethylalkynes | |
| FR2528044A1 (en) | ISOQUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING SAME | |
| EP0037777B1 (en) | Process for preparation of cycloalcoyl propanol amines useful as medicine | |
| EP0408437A2 (en) | 2 Alkylimino-benzothiazolines, process for their preparation and pharmaceuticals containing them | |
| IL29445A (en) | Phenoxyisoalkyl imidazolines and their preparation | |
| FR2649981A1 (en) | DIHYDROPYRIMIDOTHIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| EP0110748B1 (en) | Derivatives of phenyl-(3-aminopropyl) ketone, their therapeutical use and process for their preparation | |
| BE643853A (en) | ||
| US1911332A (en) | Aminoketoalcohol and process for the manufacture of same | |
| US3751423A (en) | Trichloroethylidene-amino-thiazoles | |
| FR2528040A1 (en) | BENZHYDRYLSULFINYLETHYLAMINES, PREPARATION METHOD AND THERAPEUTIC USE | |
| IL23384A (en) | Substituted benzamides and process for the manufacture thereof | |
| CH629771A5 (en) | N- (1'-ETHYL-2'-OXO-5'-PYRROLIDINYLMETHYL) BENZAMIDES. | |
| GB959057A (en) | Novel substituted ethanolamines and a process for the manufacture thereof | |
| EP0226475A1 (en) | Diphenoxyethyl amine derivatives, process for their preparation and pharmaceutical compositions containing them |